Table 7. Postoperative follow-up of early gastric cancer.
| Follow-up | Month | 1 | 3 | 6 | 9 | 12 | 15 | 18 | 21 | 24 | 27 | 30 | 33 | 36 | 39 | 42 | 45 | 48 | 51 | 54 | 56 | 60 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KGCA | Not mentioned due to lack of evidence | |||||||||||||||||||||
| JGCA | PE, PS, BW | ○ | ○ | ○ | ○ | ○ | ○ | ○ | ○ | ○ | ||||||||||||
| Blood test | ○ | ○ | ○ | ○ | ○ | ○ | ○ | ○ | ○ | |||||||||||||
| CT | ○ | ○ | ○ | ○ | ○ | ○ | ||||||||||||||||
| EGD | ○ | ○ | ○ | |||||||||||||||||||
| CSCO | PE, clinical history, blood test, Helicobacter pylori detection, nutritional status, EGD | 3–6 months for 2 years, 6–12 months until 5 years after surgery, annually thereafter | ||||||||||||||||||||
| CT | 6–12 months for 1 year, annually thereafter | |||||||||||||||||||||
| NCCN | History, PE | 3–6 months for 1–2 years, 6–12 months for 3–5 years, annually thereafter | ||||||||||||||||||||
| Blood test | As clinically indicated | |||||||||||||||||||||
| CT | As clinically indicated | |||||||||||||||||||||
| EGD | As clinically indicated | |||||||||||||||||||||
| ESMO | Different for each patient | |||||||||||||||||||||
KGCA = Korean Gastric Cancer Association; JGCA = Japanese Gastric Cancer Association; CSCO = Chinese Society of Clinical Oncology; NCCN = National Comprehensive Cancer Network; ESMO = European Society for Medical Oncology; PE = physical examination; PS = performance status; BW = body weight; CT = computed tomography; EGD, esophagogastroduodenoscopy.